Endoscopic ultrasonographic signs of portal hypertension in cirrhosis

被引:62
|
作者
Burtin, P
Cales, P
Oberti, F
Joundy, N
Person, B
Carpentier, S
Boyer, J
机构
[1] Gastroenterology, University Hospital, CHRU, 49033 Angers Cedex 1, 4, Rue Larrey
关键词
D O I
10.1016/S0016-5107(96)70161-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Endoscopic ultrasonography (EUS) has been suggested to investigate portal hypertension (PHT). We compared EUS and endoscopy in the exploration of PHT in cirrhosis. Methods: In 58 patients with cirrhosis and 16 controls, the presence of esophageal varices and gastric varices was recorded by both endoscopy and EUS, peridigestive varices and perforating veins by EUS. Relationships of patterns with each other and with clinical and biologic data were evaluated. Results: In patients with cirrhosis: esophageal varices were found by endoscopy and EUS in 88% and 55% of cirrhotic cases (p < 0.01), and gastric varices in 17% and 41%, respectively (p < 0.01). Perforating veins, below the gastroesophageal junction, were diagnosed by EUS in 40% of cases and never in controls. A significant relationship was found between perforating veins and the following patterns: peri-digestive varices, gastric varices at EUS, and esophageal varices at endoscopy. In patients with and without cirrhosis: after multivariate analysis, only esophageal varices at endoscopy were independently related to cirrhosis. However, in Child-Pugh class A patients, both esophageal varices and perforating veins were independently related to cirrhosis (diagnostic accuracy, 92%). Conclusions: EUS is of limited value in the diagnosis of cirrhosis because it gives little additional information to upper gastrointestinal endoscopy. The relationships between perforating veins, varices, and peridigestive varices support the hypothesis that perforating veins are important in the pathogenesis of esophageal and gastric varices.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [41] PORTAL HYPERTENSION IN PRIMARY BILIARY CIRRHOSIS
    KEW, MC
    VARMA, RR
    DOSSANTO.HA
    SCHEUER, PJ
    SHERLOCK, S
    GUT, 1971, 12 (10) : 830 - &
  • [42] Emerging therapies for portal hypertension in cirrhosis
    Nair, Harikumar
    Berzigotti, Annalisa
    Bosch, Jaime
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (02) : 167 - 181
  • [43] Liver surgery in cirrhosis and portal hypertension
    Christina Hackl
    Hans J Schlitt
    Philipp Renner
    Sven A Lang
    World Journal of Gastroenterology, 2016, (09) : 2725 - 2735
  • [44] Liver surgery in cirrhosis and portal hypertension
    Hackl, Christina
    Schlitt, Hans J.
    Renner, Philipp
    Lang, Sven A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (09) : 2725 - 2735
  • [45] Cirrhosis and Portal Hypertension in the Pediatric Population
    Chapin, Catherine A.
    Bass, Lee M.
    CLINICS IN LIVER DISEASE, 2018, 22 (04) : 735 - +
  • [46] Advances and challenges in cirrhosis and portal hypertension
    Berzigotti, Annalisa
    BMC MEDICINE, 2017, 15
  • [47] Endothelial dysfunction in cirrhosis and portal hypertension
    Cahill, PA
    Redmond, EM
    Sitzmann, JV
    PHARMACOLOGY & THERAPEUTICS, 2001, 89 (03) : 273 - 293
  • [48] PROPRANOLOL AND PORTAL-HYPERTENSION IN CIRRHOSIS
    WILKINSON, SP
    LANCET, 1980, 2 (8191): : 429 - 429
  • [49] Advances in the treatment of portal hypertension in cirrhosis
    Kimer, N.
    Wiese, S.
    Mo, S.
    Moller, S.
    Bendtsen, F.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (08) : 961 - 969
  • [50] Hepatic cirrhosis and portal hypertension in neuroblastoma
    Yule, SM
    Anderson, J
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (06) : 457 - 461